deoxypyridinoline has been researched along with Polymyalgia Rheumatica in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, TC; Bucknall, RC; Daroszewska, A; Fraser, WD | 1 |
| Corrigall, V; Dasgupta, B; Dolan, AL; Li, F; Mackintosh, C; Moniz, C; Panayi, GS; Todd, P | 1 |
| Barton, I; Bonvoisin, B; Cortet, B; Hachulla, E; Roux, C | 1 |
2 trial(s) available for deoxypyridinoline and Polymyalgia Rheumatica
| Article | Year |
|---|---|
Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Density; Bone Remodeling; Female; Humans; Inflammation; Injections, Intramuscular; Interleukin-6; Male; Methylprednisolone; Middle Aged; Peptide Fragments; Polymyalgia Rheumatica; Prednisolone; Procollagen; Prospective Studies | 1997 |
Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Amino Acids; Arthritis, Rheumatoid; Bone Density; Double-Blind Method; Drug Evaluation; Etidronic Acid; Female; Femur; Giant Cell Arteritis; Glucocorticoids; Humans; Lumbosacral Region; Male; Middle Aged; Osteocalcin; Osteoporosis; Polymyalgia Rheumatica; Spine | 1999 |
1 other study(ies) available for deoxypyridinoline and Polymyalgia Rheumatica
| Article | Year |
|---|---|
Bone turnover in untreated polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Density; Bone Remodeling; Bone Resorption; Female; Humans; Male; Middle Aged; Osteogenesis; Osteoporosis; Peptide Fragments; Polymyalgia Rheumatica; Procollagen | 2004 |